What does HUIDZIEKTEN DR. SIMOENS LYDIA do?

HUIDZIEKTEN DR. SIMOENS LYDIA is a specialist medical practice in Antwerpen. Private Limited, started on 26 March 1998, 1 establishment.

What is the address of HUIDZIEKTEN DR. SIMOENS LYDIA?

The registered office of HUIDZIEKTEN DR. SIMOENS LYDIA is located at Antwerpsesteenweg 4, 2660 Antwerpen.

Is HUIDZIEKTEN DR. SIMOENS LYDIA still active?

Yes. According to the CBE (2 October 2026) HUIDZIEKTEN DR. SIMOENS LYDIA is active, legal situation “Normale toestand”, started on 26 March 1998.

Is HUIDZIEKTEN DR. SIMOENS LYDIA registered on Peppol?

Yes, HUIDZIEKTEN DR. SIMOENS LYDIA is registered on the Peppol network with ID 0208:0462970409.

What is the enterprise number of HUIDZIEKTEN DR. SIMOENS LYDIA?

The enterprise number of HUIDZIEKTEN DR. SIMOENS LYDIA is BE0462970409.

When was HUIDZIEKTEN DR. SIMOENS LYDIA founded?

HUIDZIEKTEN DR. SIMOENS LYDIA was founded on 26 March 1998.

Who are the directors of HUIDZIEKTEN DR. SIMOENS LYDIA?

According to the 2025 annual accounts, the directors of HUIDZIEKTEN DR. SIMOENS LYDIA are: Lydia Simoens.

Is HUIDZIEKTEN DR. SIMOENS LYDIA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 March 1998; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did HUIDZIEKTEN DR. SIMOENS LYDIA make in 2025?

HUIDZIEKTEN DR. SIMOENS LYDIA posted a profit after taxes of € 28,404 in financial year 2025.

What is the revenue of HUIDZIEKTEN DR. SIMOENS LYDIA?

As a small company, HUIDZIEKTEN DR. SIMOENS LYDIA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 57,102.

HUIDZIEKTEN DR. SIMOENS LYDIA (Private Limited)

Dossier HUIDZIEKTEN DR. SIMOENS LYDIA, printed on 2 October 2026 from databakkes.be/en/0462970409/huidziekten-dr-simoens-lydia. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Figures corrected NBB

Corrected annual account filed for 2024.

Financials

Financial year 2025

HUIDZIEKTEN DR. SIMOENS LYDIA from Antwerpen, company number BE0462970409, closed financial year 2025 with a result of € 28,404 after tax. For that financial year HUIDZIEKTEN DR. SIMOENS LYDIA recorded a gross margin of € 57,102 and equity of € 476,365. Compared with financial year 2024, the result moved from € 77,282 to € 28,404. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 476,365

▲ 6% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 28,404

▼ 63% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 371,868

▼ 29% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 392,365.

People and assets in 2025

Vehicles and equipment

€ 39,142

▼ 21% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 6,877

▼ 19% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 10,915

▼ 33% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 112,811 Gross margin 2022: € 112,811 First fiscal year in the series	€ 129,610 Gross margin 2023: € 129,610 ▲ 15% vs 2022 (€ 112,811) Favourable step	€ 123,468 Gross margin 2024: € 123,468 ▼ 5% vs 2023 (€ 129,610) Unfavourable step	€ 57,102 Gross margin 2025: € 57,102 ▼ 54% vs 2024 (€ 123,468) Unfavourable step	▼ 54%
Profit after taxes	€ 66,169 Profit after taxes 2022: € 66,169 First fiscal year in the series	€ 80,675 Profit after taxes 2023: € 80,675 ▲ 22% vs 2022 (€ 66,169) Favourable step	€ 77,282 Profit after taxes 2024: € 77,282 ▼ 4% vs 2023 (€ 80,675) Unfavourable step	€ 28,404 Profit after taxes 2025: € 28,404 ▼ 63% vs 2024 (€ 77,282) Unfavourable step	▼ 63%
Equity	€ 357,002 Equity 2022: € 357,002 First fiscal year in the series	€ 437,677 Equity 2023: € 437,677 ▲ 23% vs 2022 (€ 357,002) Favourable step	€ 447,961 Equity 2024: € 447,961 ▲ 2% vs 2023 (€ 437,677) Favourable step	€ 476,365 Equity 2025: € 476,365 ▲ 6% vs 2024 (€ 447,961) Favourable step	▲ 6%
Total debts	€ 254,269 Total debts 2022: € 254,269 First fiscal year in the series	€ 137,246 Total debts 2023: € 137,246 ▼ 46% vs 2022 (€ 254,269) Favourable step	€ 201,147 Total debts 2024: € 201,147 ▲ 47% vs 2023 (€ 137,246) Unfavourable step	€ 17,791 Total debts 2025: € 17,791 ▼ 91% vs 2024 (€ 201,147) Favourable step	▼ 91%
Cash	€ 409,577 Cash 2022: € 409,577 First fiscal year in the series	€ 382,869 Cash 2023: € 382,869 ▼ 7% vs 2022 (€ 409,577) Unfavourable step	€ 521,775 Cash 2024: € 521,775 ▲ 36% vs 2023 (€ 382,869) Favourable step	€ 371,868 Cash 2025: € 371,868 ▼ 29% vs 2024 (€ 521,775) Unfavourable step	▼ 29%
Land & buildings	€ 62,388 Land & buildings 2022: € 62,388 First fiscal year in the series	€ 50,550 Land & buildings 2023: € 50,550 ▼ 19% vs 2022 (€ 62,388) Unchanged	€ 38,712 Land & buildings 2024: € 38,712 ▼ 23% vs 2023 (€ 50,550) Unchanged	€ 26,874 Land & buildings 2025: € 26,874 ▼ 31% vs 2024 (€ 38,712) Unchanged	▼ 31%
Retained profit	€ 273,002 Retained profit 2022: € 273,002 First fiscal year in the series	€ 353,677 Retained profit 2023: € 353,677 ▲ 30% vs 2022 (€ 273,002) Favourable step	€ 363,961 Retained profit 2024: € 363,961 ▲ 3% vs 2023 (€ 353,677) Favourable step	€ 392,365 Retained profit 2025: € 392,365 ▲ 8% vs 2024 (€ 363,961) Favourable step	▲ 8%
Dividend	€ 15,833 Dividend 2022: € 15,833 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 15,833) Unchanged	€ 66,998 Dividend 2024: € 66,998 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 66,998) Unchanged	▼ 100%
Bank debt	€ 444 Bank debt 2022: € 444 First fiscal year in the series	€ 10 Bank debt 2023: € 10 ▼ 98% vs 2022 (€ 444) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 10) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 611,271 Balance sheet total 2022: € 611,271 First fiscal year in the series	€ 574,923 Balance sheet total 2023: € 574,923 ▼ 6% vs 2022 (€ 611,271) Unchanged	€ 649,108 Balance sheet total 2024: € 649,108 ▲ 13% vs 2023 (€ 574,923) Unchanged	€ 494,156 Balance sheet total 2025: € 494,156 ▼ 24% vs 2024 (€ 649,108) Unchanged	▼ 24%

Key figures of HUIDZIEKTEN DR. SIMOENS LYDIA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to HUIDZIEKTEN DR. SIMOENS LYDIA?

What happened at HUIDZIEKTEN DR. SIMOENS LYDIA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 28,404 (▼ 63% vs 2024). filed late Source: NBB ↗
Mar 26, 1998 New establishment in Antwerpen. KBO
Mar 26, 1998 Start of the company according to the CBE. KBO
1998 Lydia Simoens became a director. NBB

In short

From € 66,169 profit in 2022 to € 28,404 profit in 2025.

Paid € 105,939 in corporate taxes since 2022.

Best year ever: 2023, with € 80,675 profit.

Paid out € 82,831 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at HUIDZIEKTEN DR. SIMOENS LYDIA? We notify you, reason included.

Follow HUIDZIEKTEN DR. SIMOENS LYDIA

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Lydia Simoens

HUIDZIEKTEN DR. SIMOENS LYDIA

Behind HUIDZIEKTEN DR. SIMOENS LYDIA is Lydia Simoens.

See the full network in the app

Directors

According to the 2025 annual accounts

Lydia Simoens

Manager

since 1998

Establishments

Establishment units

Physical locations of this company

Registered office

Antwerpsesteenweg 4

2660 Antwerpen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0462.970.409
VAT number: BE 0462.970.409
Registered office: Antwerpsesteenweg 4, 2660 Antwerpen
Names & denominations: HUIDZIEKTEN DR. SIMOENS LYDIA
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 26 March 1998
Peppol: Active · Active since 18 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗